StockWatch
·

Neogen Chemicals Ltd Q1 FY26 Results

NEOGENQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue186.737.9%
Total Income187.917.6%
Expenditure173.676.5%
PBT14.24292.3%
Net Profit10.26325.7%
OPM16.87%5.88pp
NPM5.46%4.28pp
EPS3.89327.5%
View full financials

Neogen Chemicals Reports Steady Q1 FY26 Performance Despite Dahej Plant Unavailability

02 Aug 2025 · 2 Aug 2025, 10:21 pm

Summary

Neogen Chemicals Limited reported steady financial performance for the first quarter ended 30th June, 2025. Despite the Dahej plant being unavailable for the entire quarter due to a fire incident, the company achieved a 4% YoY increase in revenues, which stood at INR 187 crore. The performance was driven by sustained volume growth in the core business and the initiation of sales from Neogen lonics. The EBITDA for Q1 FY26 is INR 32 crore, higher by 2% Y-o-Y, with an EBITDA Margin of 16.9%. The company maintained steady EBITDA performance due to favorable product mix and ongoing cost optimization initiatives. The profit after tax for Q1 FY26 stood at INR 10 crore.

Key Highlights

  1. 1

    Q1 FY26 revenues stood at INR 187 crore, higher by 4% YoY

  2. 2

    Dahej plant was unavailable for the entire quarter due to a fire incident

  3. 3

    Performance steered by sustained volume growth in the core business

  4. 4

    Neogen lonics’ Q1 FY26 revenue stood at INR 5.4 crore

  5. 5

    EBITDA for Q1 FY26 is INR 32 crore, higher by 2% Y-o-Y

  6. 6

    EBITDA Margin stood at 16.9%

  7. 7

    Profit after tax for Q1 FY26 stood at INR 10 crore

  8. 8

    Neogen is building a stronger, more diversified Company, ready to capitalize on future opportunities

  9. 9

    Received INR 80.55 crore in claim payments from insurance company

  10. 10

    Replacement plant being built at an adjacent location within the same site; to be operational by next year

  11. 11

    CRISIL has reaffirmed its credit rating: Long-term: CRISIL A/Negative, Short-term: CRISIL A1

Management Comments

M

Mr. Haridas Kanani

We delivered a resilient performance in Q1 FY26, demonstrating the inherent strength of our diversified business model, even with our Dahej plant unavailable for the entire quarter due to the unfortunate fire. Volume-driven growth was propelled by our base business. Additionally, Neogen lonics began contributing by initiating Commercial Sales in both Electrolyte and Lithium Electrolyte Salts. Despite the prevailing soft pricing environment, we effectively maintained our performance showcasing the strength and agility of our business model. Our strategic initiatives are moving forward with good momentum, as is our recovery from the fire incident. We have secured initial insurance claims and the rebuilding of our Dahej plant is progressing swiftly aiming for completion by next year. Concurrently, our greenfield facility at Pakhajan for Electrolyte and Lithium Salts is taking shape, with key milestones accomplished and vital equipment ordered. This project is a cornerstone of our future growth. Looking ahead, our vision for Neogen Chemicals remains ambitious and clearly defined. The proposed JV with Morita is a testament to our long-term strategy, firmly positioning us in the rapidly growing battery chemicals sector. While we have adjusted our near-term revenue guidance to reflect current operational realities, our long-term trajectory is robust. We are confidently building a stronger, more diversified Company, ready to capitalize on future opportunities.

Informational and educational content only. Not investment advice.